Semaglutide improves insulin resistance by slowing gastric emptying, stimulating insulin secretion, and enhancing beta cell function, which improves the body's ability to use insulin effectively
In the pivotal SURMOUNT trials evaluating tirzepatide for weight management, participants experienced average systolic blood pressure reductions of 6-8 mmHg and diastolic reductions of 2-4 mmHg compared to placebo over 72 weeks
If you or a loved one suffered an injury in a motorcycle accident in St
Starting at $135/month Best for: Patients looking for steady appetite control for supported weight loss Starting at $135/month Best for: Patients looking for steady appetite control for supported weight loss By targeting multiple pathways involved in appetite and metabolism, this option offers a more advanced approach to hunger regulation
The European Medicines Agency reviewed GLP-1 receptor agonists in 2024 and found no causal link between these medications and depression or suicidal thoughts, though monitoring continues
FDA breakthrough therapy designation: evaluating the quality of the evidence behind the drug approvals